MeiraGTx Holdings plc

MeiraGTx Holdings plc is not a good value stock. MeiraGTx Holdings plc is not a good growth stock. Tradey thinks it is not wise to invest in MeiraGTx Holdings plc.
Log in to see more information.
MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel...

News

Perceptive Advisors Llc Purchases 1,250,000 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) Stock
Perceptive Advisors Llc Purchases 1,250,000 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) Stock

Ticker Report MeiraGTx Holdings plc (NASDAQ:MGTX - Get Free Report) Director Perceptive Advisors Llc acquired 1,250,000 shares of the company's stock in a transaction that occurred on Monday, August 12th. The...\n more…

MeiraGTx Holdings Second Quarter 2024 Earnings: Misses Expectations
MeiraGTx Holdings Second Quarter 2024 Earnings: Misses Expectations

Simply Wall St MeiraGTx Holdings ( NASDAQ:MGTX ) Second Quarter 2024 Results Key Financial Results Net loss: US$48.6m (loss widened by...\n more…

MeiraGTx Holdings plc (NASDAQ:MGTX): Are Analysts Optimistic?
MeiraGTx Holdings plc (NASDAQ:MGTX): Are Analysts Optimistic?

Simply Wall St MeiraGTx Holdings plc ( NASDAQ:MGTX ) is possibly approaching a major achievement in its business, so we would like to...\n more…

MGTX Stock Earnings: MeiraGTx Hldgs Misses EPS, Misses Revenue for Q2 2024
MGTX Stock Earnings: MeiraGTx Hldgs Misses EPS, Misses Revenue for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nMGTX stock results show that MeiraGTx Hldgs missed analyst estimates for earnings per share and missed on revenue for the second quarter...\n more…

MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational Results
MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational Results

Globe Newswire - Positive data from the Phase 1 AQUAx study in radiation-induced xerostomia (RIX) presented at the American Academy of Oral Medicine 2024 annual meeting (AAOM) showed meaningful improvements in...\n more…

MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi

Globe Newswire LONDONandNEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicine company, today announced the pricing...\n more…